 |
| Mosquito Borne Disease Market Size |
The mosquito borne disease market involves products such as diagnostic
equipment, therapeutic drugs, and preventive vaccines for mosquito borne
diseases like malaria, dengue, chikungunya, Zika virus, yellow fever, and
others. The increasing prevalence of mosquito borne diseases due to factors
like changing climate conditions, urbanization, and international travel &
trade has created a high demand for diagnostic tests, drugs, and vaccines to
diagnose and treat these diseases. The growing awareness regarding mosquito
borne disease diagnosis and management is also propelling the market growth.
The Global mosquito borne disease market is estimated to be valued at US$ 3.59 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period
2024 to 2030.
Key Takeaways
Key players operating in the Mosquito
Borne Disease Market Size are Masimo, Medtronic Plc, Nihon-Kohden
Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services,
Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International
Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd.,
ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell
Medical Products, Inc., and Ecomed. The market players are focusing on new
product launches, mergers, acquisitions, and global expansion to strengthen
their market presence.
The rising global burden of mosquito borne diseases and growing demand for
advanced diagnosis and treatment options provide numerous opportunities for
market players to invest in R&D and launch innovative and low-cost
products. Additionally, with increasing global healthcare expenditures, rising
awareness in developing regions, and supportive government initiatives, the
mosquito borne disease market is expected to witness robust growth in emerging
markets of Asia Pacific, Latin America, Middle East, and Africa in the coming
years.
Market Drivers and Restraints
The key drivers for the mosquito borne disease market include the growing
prevalence of mosquito borne diseases globally, rising healthcare expenditure
in developing nations, increasing focus on mosquito control and elimination
programs, and technological advancements in diagnostic devices and testing
kits. As per the WHO, there were about 228 million cases of malaria reported
worldwide in 2018 alone. Additionally, diseases like dengue, zika and
chikungunya are also on the rise across tropical and subtropical regions. This
has boosted the demand for effective diagnostic testing and therapeutic drugs.
However, high costs associated with advanced disease diagnostic devices and
lack of awareness regarding disease symptoms in remote areas hampers the market
growth. Additionally, lack of healthcare infrastructure and shortage of skilled
professionals in developing regions also poses challenges. Compliance issues
with diagnostic procedures and ambiguity over disease symptoms also act as a
restraint.
Segment Analysis
The mosquito borne disease market can be segmented based on diseases into
Malaria, Dengue, Chikungunya, Zika virus, filariasis, Japanese encephalitis and
others. Among these, the malaria segment accounts for the highest share of the
market presently as malaria accounts for over 200 million cases annually across
the world as per WHO report. It is considered as one of the most dominant and
deadly mosquito borne disease which contributes significantly to global disease
burden.
The market can also be segmented based on product type into diagnostic
instruments, rapid diagnostic tests (RDTs), Drugs & Vaccines, repellents
and others. Among these, the rapid diagnostic tests (RDTs) segment dominates
the market currently due to the emergence of affordable and easy-to-use RDT
kits for malaria, dengue and chikungunya. Early diagnosis of such diseases is
crucial for efficient treatment and disease management.
Regional Analysis
The Asia Pacific region accounts for the largest share in the mosquito borne
disease market due to high disease prevalence and developing nations like India
and China facing challenges due to disease burden and lack of adequate
diagnostic facilities. As per recent WHO report, around 88% of estimated global
malaria cases occur in Africa region alone making it the dominating region.
Latin American countries are also vulnerable to mosquito borne diseases like
dengue, zika and chikungunya accounting for significant market share. Developed
regions like North America and Europe also contribute to the market growth due
to increasing global travel and international trade activities.
Get More Insights On This Topic: Mosquito
Borne Disease Market